Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

Julia U Holle,Eva Reinhold-Keller,Christin Dubrau,Bernhard Noelle,Martin Heller,Wolfgang L Gross,Petra Ambrosch,Karen Herlyn

doi:10.1136/ard.2011.153601

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

Julia U Holle, Eva Reinhold-Keller + Show 6 more

https://doi.org/10.1136/ard.2011.153601

Copy DOI

Journal: Annals of the Rheumatic Diseases	Publication Date: Oct 21, 2011
Citations: 166

Affiliation: University Hospital Schleswig-Holstein, University of Lübeck, HNO Bad Bramstedt, Kiel University

#Granulomatous Manifestations #Vasculitic Manifestations + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectiveFirst, to investigate the overall efficacy and safety of rituximab (RTX) in refractory granulomatosis with polyangiitis (GPA) in a tertiary referral centre. Second, to compare the efficacy of RTX in...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.